<?xml version="1.0" encoding="UTF-8"?>
<p id="Par87">At approximately 100 days post-ASCT, patients will be assessed for response. A minimum of 248 patients achieving or maintaining at least MR and fulfilling eligibility criteria (Table 
 <xref rid="Tab3" ref-type="table">3</xref>) for continuation on trial will proceed to second randomisation (R2).
</p>
